Streetbeat News

Stock Prices

RVPH

Shares of Reviva Pharmaceuticals were halted on a circuit breaker to the upside, with the stock now up by 45.1%.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 4:05 pm

CBIO

GYRE

Catalyst Biosciences has completed its business combination with GNI Group Ltd. and related entities, and will now operate as Gyre Therapeutics, Inc., trading under the symbol 'GYRE'. The company also implemented a 1-for-15 reverse stock split. Beijing Continent Pharmaceuticals became a majority-owned subsidiary of Gyre as a result of the combination. The changes are effective from October 31, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 4:02 pm

AGCO

AGCO (NYSE:AGCO) is set to release its latest quarterly earnings report on Tuesday, 2023-10-31. Analysts estimate an earnings per share (EPS) of $3.29. Last quarter, the company beat EPS by $0.56, which was followed by a 0.03% drop in the share price. Shares of AGCO were trading at $110.64 as of October 27, and over the last 52-week period, shares are down 4.28%.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 4:02 pm

BLD

TopBuild (NYSE:BLD) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $4.56. The company's past performance shows it beat EPS estimates last quarter, resulting in a 3.22% increase in share price. TopBuild's shares were trading at $218.64 as of October 27, with a 52-week increase of 39.31%.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 4:02 pm

MCOM

Micromobility.com Inc. (NASDAQ:MCOM) shares are trading higher, despite being down by over 30% in the last month. The company, which provides electric micro-mobility services, recently announced the signing of a letter of intent with Atlas Special Opportunities regarding Hopium. The potential investment of up to $15 million would accelerate Hopium's R&D and growth. MCOM shares are up nearly 10% at 4 cents.

Portfolio Pulse from Erica Kollmann

October 30, 2023 | 4:02 pm

STVN

Stevanato Gr (NYSE:STVN) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $0.16. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $28.72, up 71.77% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 4:01 pm

CCJ

Cameco (NYSE:CCJ) is set to release its quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $0.09. The company's past performance shows a trend of share price increase following the earnings release, regardless of whether the EPS estimate was met. The stock is currently trading at $37.93, up 59.16% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 4:01 pm

EPD

Enterprise Prods Partners (NYSE:EPD) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $0.64. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares were trading at $26.58 as of October 27, with a 52-week increase of 5.66%.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 4:01 pm

CVX

Chevron Corporation's shares recovered slightly after a significant drop due to disappointing Q3 earnings. The drop wiped off 90% of the pre-deal value of Hess, according to BofA Securities. Analyst Doug Leggate upgraded Chevron's rating from Neutral to Buy and raised the price target from $190 to $200. Leggate believes the successful completion of the Hess acquisition would reset the investment outlook for Chevron.

Portfolio Pulse from Priya Nigam

October 30, 2023 | 4:01 pm

ARES

Ares Management (NYSE:ARES) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $0.87. The company's past performance shows a pattern of beating EPS estimates, but this has sometimes been followed by a drop in share price. Ares Management's shares were trading at $100.84 as of October 27, with a 52-week increase of 30.52%.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 4:01 pm